Phenaris

Phenaris is a partner of the recently established EU-ToxRisk Commercial Platform for New Approach Methods (NAMs) in Safety Assessment

At Phenaris we constantly challenge the status quo in computational drug design and in silico toxicology.

Using cutting edge technologies we provide data, models, and decision support in all aspects of in silico toxicology. We are currently working on multiple solutions to provide data integration, model development, and decision support.

https://www.phenaris.com/

Latest Tweets

Edelweiss Connect (2 days ago)
Another upcoming #SaferWorldbyDesign webinar: Safety testing of cosmetic products: Overview of established methods… https://t.co/FbfJPcUuxX
Edelweiss Connect (2 days ago)
Join us next week for a #SaferWorldbyDesign webinar: A Novel QSAR Platform to Identify Endocrine Disrupting Chemica… https://t.co/bP9J7bgG22
Edelweiss Connect (2 months ago)
Dynamic gene expression profiling of the HepaRG™ cell line #HepaRG #invitro #cellculture #BiotechNews See the n… https://t.co/dPow2PDDXK
Edelweiss Connect (2 months ago)
RT @barryhardy: Trusted Evidence in Public Health - combining #dataintegrity, #ArtificialIntelligence and #MachineLearning learning in pre…
Edelweiss Connect (3 months ago)
Watch our latest #SaferWorldbyDesign panel discussion: In Vitro Biology and Toxicology: Emerging Methods and Best P… https://t.co/cXF7alwRzC

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA